A three-part event to engage scientists, clinicians, industry, funders and community representatives on experimental medicine to progress HIV vaccine development efforts.
This webinar looks into planned and ongoing experimental medicine trials for the development of HIV vaccines. Strategy, products and trial design will be reviewed and discussed to identify the most promising areas for development.
Nina Russell
Director of HIV Prevention and Tuberculosis
Bill & Melinda Gates Foundation, USA
William Schief
Professor
Department of Immunology and Microbiology, Scripps, USA
Ansuya Naidoo
Medical Director
IAVI, South Africa
Robin Shattock
Professor of Mucosal Infection and Immunity
Imperial College London, UK
Ann Arvin
Senior Vice President
VIR Biotechnology, USA
William Schief
Professor
Department of Immunology and Microbiology, Scripps, USA
Robin Shattock
Professor of Mucosal Infection and Immunity
Imperial College London, UK
Jim Kublin
Executive Director
HIV Vaccine Trials Network, USA
Ansuya Naidoo
Medical Director
IAVI, South Africa
Brett Leav
Vice President
Clinical Development, Public Health Vaccines, Moderna, USA
Stacey Hannah
Director of Research Engagement
AVAC, USA
Ann Arvin
Senior Vice President
VIR Biotechnology, USA